Skip to main content
. 2018 Jan 26;26(4):518–526. doi: 10.1038/s41431-017-0083-1

Table 3.

Multivariate analyses of patient satisfaction with pre- and post-test genetic counselling (models 1 and 2), perceived collaboration between caregivers in the genetic testing pathway (model 3) and perceived improvement in quality of life by type of genetic test (model 4)

OR 95% CI p-value
Patient satisfaction with pre-test genetic counselling (model 1)
Type of genetic test
  APC test a 7.13a 1.08 - infa 0.039a
  BRCA1/2 tests 6.00 1.19–30.36 0.030
  Thrombophilia tests (reference) 1.00
Carrier status (reference = non-carrier) 0.44 0.11–1.81 0.254
Patient satisfaction with post-test genetic counselling (model 2)
Type of genetic testing
   APC test 18.97 2.46–146.36 0.005
   BRCA1/2 tests 32.44 7.07–148.88 <0.001
   Thrombophilia tests (reference) 1.00
Carrier status (reference = non-carrier) 1.03 0.41–2.58 0.948
Patient experience of collaboration between caregivers (model 3)
Type of genetic test
   APC test 0.28 0.08–1.08 0.064
   BRCA1/2 tests 0.49 0.17–1.37 0.174
   Thrombophilia tests (reference) 1.00
Carrier status (reference = non-carrier) 1.08 0.52–2.26 0.830
Type of health professional referring patient for test
   Geneticist 0.43 0.11–1.71 0.232
   Specialist 0.22 0.07–0.77 0.017
   Primary care physician (reference) 1.00
Post-test genetic counselling
  Yes, by a geneticist 2.20 0.83–5.85 0.113
  Yes, by a specialist 0.55 0.19–1.58 0.269
  Yes, by both a geneticist and a specialist 8.53 2.75–26.43 <0.001
   No (reference) 1.00
   Familiarity (reference = no) 2.39 1.02–5.60 0.045
Self-perceived improvement in life quality (model 4)
Type of genetic test
   APC test 2.97 1.14–7.72 0.025
    BRCA1/2 tests 1.41 0.74–2.69 0.294
   Thrombophilia tests (reference) 1.00
Carrier status (reference = non-carrier) 0.52 0.28–0.97 0.040
Gender (reference = male) 1.78 0.91–3.47 0.088

a Exact logistic regression was used because of convergence failure, median unbiased estimate, 95% CI and exact p-value were reported for dummy APC testing [14].